This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center



Partner with Agilent’s Nucleic Acid Solutions Division and benefit from our industry leading experience. Efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety.

Our Boulder and Frederick, Colorado manufacturing sites are U.S. Food & Drug Administration (FDA) inspected fa¬cilities and our business is accredited as a foreign manufacturer for non-sterile drugs by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA).